The Business Of Neurotech
From breakthrough devices to the bottom line. The Business of Neurotech is the premier podcast dedicated to the commercial trends, investment strategies, and innovative business models shaping the neuroscience economy. Hosted by Adam Fraser, this series moves beyond the lab to explore how groundbreaking research in neuromodulation, BCI, and medical devices is transformed into viable, scalable enterprises. +2 Each episode features candid, fireside-chat interviews with the ecosystem's most influential voices—from founders and CEOs to venture capitalists and strategic leaders. We dive into the "how" and "why" behind the headlines, discussing market maturity, regulatory hurdles, and the go-to-market strategies required to br...
Michael Brotherton Talks Neurotech Market Dynamics and Neurotech Investing
What does it really take to turn neurotechnology into a scalable business? In this episode of The Business of Neurotech, host Adam Fraser sits down with Michael Brotherton, co-founder and managing partner at Dragonfly 44, to explore the capital, strategy, and market forces shaping the sector. Michael talks about his journey from science into investment banking and how this ultimately led him to establish a business specialising in neuroscience and neurotechnology. He then delves into his definition of neuroscience and neurotech across devices, diagnostics, therapeutics, BCI, and digital tools. Adam and Michael also dig into the surge of investor interest...
